CHIO', Adriano
 Distribuzione geografica
Continente #
NA - Nord America 12.788
EU - Europa 11.809
AS - Asia 5.519
OC - Oceania 756
SA - Sud America 603
AF - Africa 243
Continente sconosciuto - Info sul continente non disponibili 17
Totale 31.735
Nazione #
US - Stati Uniti d'America 11.839
IT - Italia 3.226
CN - Cina 2.401
DE - Germania 1.714
GB - Regno Unito 1.597
NL - Olanda 1.024
FR - Francia 940
JP - Giappone 851
CA - Canada 778
ES - Italia 731
AU - Australia 696
IN - India 471
IE - Irlanda 312
BR - Brasile 309
VN - Vietnam 283
KR - Corea 243
TR - Turchia 222
PT - Portogallo 215
SE - Svezia 215
PL - Polonia 211
BE - Belgio 207
HK - Hong Kong 207
TW - Taiwan 181
DK - Danimarca 179
CZ - Repubblica Ceca 157
RU - Federazione Russa 153
CH - Svizzera 150
AT - Austria 135
MX - Messico 129
FI - Finlandia 118
ZA - Sudafrica 104
IL - Israele 100
GR - Grecia 98
CL - Cile 97
SG - Singapore 96
RO - Romania 87
UA - Ucraina 76
IR - Iran 74
CO - Colombia 71
NO - Norvegia 66
AR - Argentina 60
NZ - Nuova Zelanda 59
ID - Indonesia 55
PK - Pakistan 52
JO - Giordania 44
PH - Filippine 41
MY - Malesia 38
LT - Lituania 28
PE - Perù 28
HR - Croazia 26
BG - Bulgaria 25
EG - Egitto 25
EC - Ecuador 24
HU - Ungheria 24
NG - Nigeria 23
SA - Arabia Saudita 22
TH - Thailandia 22
UG - Uganda 22
MO - Macao, regione amministrativa speciale della Cina 21
TN - Tunisia 18
SI - Slovenia 17
BD - Bangladesh 16
PA - Panama 16
AE - Emirati Arabi Uniti 15
MK - Macedonia 15
RS - Serbia 14
IQ - Iraq 13
KE - Kenya 13
LB - Libano 13
SK - Slovacchia (Repubblica Slovacca) 13
CR - Costa Rica 12
LU - Lussemburgo 11
EU - Europa 10
IS - Islanda 10
CY - Cipro 9
UY - Uruguay 9
GT - Guatemala 8
MA - Marocco 7
A2 - ???statistics.table.value.countryCode.A2??? 6
GH - Ghana 6
KZ - Kazakistan 6
BH - Bahrain 5
CG - Congo 4
DZ - Algeria 4
ET - Etiopia 4
LV - Lettonia 4
BY - Bielorussia 3
PS - Palestinian Territory 3
TZ - Tanzania 3
AM - Armenia 2
GE - Georgia 2
KH - Cambogia 2
LK - Sri Lanka 2
ME - Montenegro 2
NA - Namibia 2
OM - Oman 2
QA - Qatar 2
SC - Seychelles 2
SR - Suriname 2
VE - Venezuela 2
Totale 31.711
Città #
Fairfield 1.001
Houston 714
Ashburn 677
Woodbridge 604
Santa Cruz 574
Seattle 505
Ann Arbor 477
Beijing 472
Torino 463
Cambridge 425
Buffalo 389
Wilmington 378
Utrecht 279
Shanghai 253
Milan 249
London 210
Dong Ket 204
Chengdu 180
Dublin 170
Guangzhou 162
Rome 151
Taipei 146
Tokyo 145
San Diego 144
New York 142
Warsaw 131
Wuhan 131
Chicago 130
Paris 127
Pisa 119
Toronto 115
Hangzhou 111
Turin 110
Los Angeles 108
Sydney 105
Amsterdam 102
Ottawa 100
Mountain View 99
San Francisco 96
Bengaluru 85
Nanjing 85
University Park 85
Barcelona 84
Central District 76
Vienna 76
Sanayi 74
Madrid 71
Melbourne 68
Changsha 67
Nürnberg 67
Rochester 66
Las Vegas 65
Redmond 63
Munich 60
Seoul 58
Helsinki 57
Muizenberg 57
Bologna 51
Central 49
Dallas 49
Oxford 49
Brisbane 48
Santiago 48
Istanbul 47
Delhi 46
Montréal 45
Atlanta 44
Boardman 44
Hamilton 44
Leawood 44
Singapore 44
Amman 43
Copenhagen 43
Lisbon 43
Philadelphia 43
Madison 42
Clearwater 41
Pittsburgh 41
Council Bluffs 38
Edmonton 38
Phoenix 38
Berlin 37
Boston 37
Athens 36
Montreal 36
Jinan 35
San Jose 35
Yokohama 35
Duncan 34
Lake Forest 34
Valencia 34
Bogotá 33
Durham 33
Islamabad 33
Washington 33
Hebei 32
Manchester 32
Menlo Park 32
Riva 32
Sheffield 32
Totale 13.669
Nome #
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model, file e27ce42c-c69b-2581-e053-d805fe0acbaa 3.934
State of play in amyotrophic lateral sclerosis genetics, file e27ce426-f25f-2581-e053-d805fe0acbaa 2.371
Amyotrophic lateral sclerosis, file e27ce42d-2321-2581-e053-d805fe0acbaa 1.732
Amyotrophic lateral sclerosis: moving towards a new classification system, file e27ce42b-c9d5-2581-e053-d805fe0acbaa 1.632
Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial, file e27ce42c-af2c-2581-e053-d805fe0acbaa 1.328
Disease-modifying therapies in amyotrophic lateral sclerosis, file e27ce431-c656-2581-e053-d805fe0acbaa 1.297
Pain in amyotrophic lateral sclerosis, file e27ce42d-968c-2581-e053-d805fe0acbaa 1.049
Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study, file e27ce427-cd76-2581-e053-d805fe0acbaa 629
Network Analysis Identifies Disease-Specific Pathways for Parkinson’s Disease, file e27ce42b-a2eb-2581-e053-d805fe0acbaa 622
The changing picture of amyotrophic lateral sclerosis: lessons from European registers, file e27ce42b-7da0-2581-e053-d805fe0acbaa 586
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene, file e27ce42c-62f0-2581-e053-d805fe0acbaa 542
Multicentre, population-based, case-control study of particulates, combustion products and amyotrophic lateral sclerosis risk, file e27ce42f-2e92-2581-e053-d805fe0acbaa 397
C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson’s disease complicated by psychosis or dementia in a Sardinian population, file e27ce428-b24a-2581-e053-d805fe0acbaa 394
Amyotrophic lateral sclerosis and food intake, file e27ce42d-7b57-2581-e053-d805fe0acbaa 378
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients, file e27ce428-bd7e-2581-e053-d805fe0acbaa 335
Specialist palliative care improves the quality of life in advanced neurodegenerative disorders: NE-PAL, a pilot randomised controlled study, file e27ce42b-96d5-2581-e053-d805fe0acbaa 335
The role of arterial blood gas analysis (ABG) in amyotrophic lateral sclerosis respiratory monitoring, file e27ce430-0ec6-2581-e053-d805fe0acbaa 321
Validation of the revised classification of cognitive and behavioural impairment in ALS, file e27ce430-7b4f-2581-e053-d805fe0acbaa 284
A Multicentric Prospective Incidence Study of Guillain-Barre Syndrome in Italy. the ITANG Study, file e27ce428-b7be-2581-e053-d805fe0acbaa 278
NADPH oxidase 2 (NOX2) enzyme activation in patients with chronic inflammatory demyelinating polyneuropathy, file e27ce428-bd81-2581-e053-d805fe0acbaa 273
Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis, file fc3acdb8-45e9-481c-8767-2ee0fcbf936a 271
Incidence of amyotrophic lateral sclerosis in the province of Novara, Italy, and possible role of environmental pollution, file e27ce42b-c1ab-2581-e053-d805fe0acbaa 256
Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis, file 60658d81-4a89-478e-a2cf-743fdda88669 253
Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials?, file e27ce42b-88fc-2581-e053-d805fe0acbaa 245
Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR, file e27ce42f-27e0-2581-e053-d805fe0acbaa 245
Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels., file e27ce427-db11-2581-e053-d805fe0acbaa 239
Projected increase in amyotrophic lateral sclerosis from 2015 to 2040, file e27ce42a-dbfc-2581-e053-d805fe0acbaa 237
Coffee and Amyotrophic Lateral Sclerosis: A Possible Preventive Role, file e27ce42b-aa9e-2581-e053-d805fe0acbaa 233
The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease, file e27ce428-b7c2-2581-e053-d805fe0acbaa 229
Molecular Chaperones in the Pathogenesis of Amyotrophic Lateral Sclerosis: The Role of HSPB1, file e27ce42b-aa9f-2581-e053-d805fe0acbaa 229
G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo, file e27ce42c-490d-2581-e053-d805fe0acbaa 229
Use of genetic testing in amyotrophic lateral sclerosis by neurologists, file e27ce42b-8d2f-2581-e053-d805fe0acbaa 221
Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis, file e27ce433-a050-2581-e053-d805fe0acbaa 214
A genome-wide association study of myasthenia gravis, file e27ce428-b818-2581-e053-d805fe0acbaa 208
MRI signatures of the frontotemporal lobar degeneration continuum, file e27ce428-bd79-2581-e053-d805fe0acbaa 208
A20 in Multiple Sclerosis and Parkinson’s Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways?, file e27ce42b-919f-2581-e053-d805fe0acbaa 207
Acoustic reflex patterns in amyotrophic lateral sclerosis, file e27ce42d-6c5e-2581-e053-d805fe0acbaa 207
Large Proportion of Amyotrophic Lateral Sclerosis Cases in Sardinia Due to a Single Founder Mutation of the TARDBP Gene, file e27ce426-be58-2581-e053-d805fe0acbaa 204
Alcohol and amyotrophic lateral sclerosis: A possible neuroprotective effect, file e27ce428-bd7b-2581-e053-d805fe0acbaa 204
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry, file e27ce42a-7548-2581-e053-d805fe0acbaa 202
SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, file e27ce426-ec3d-2581-e053-d805fe0acbaa 199
null, file e27ce431-6a8b-2581-e053-d805fe0acbaa 193
Age-related penetrance of the C9orf72 repeat expansion, file e27ce42b-bf10-2581-e053-d805fe0acbaa 181
The NGS technology for the identification of genes associated with the ALS. A systematic review, file e27ce432-01ed-2581-e053-d805fe0acbaa 174
C9ORF72 hexanucleotide repeat exerts toxicity in a stable, inducible motor neuronal cell model, which is rescued by partial depletion of Pten, file e27ce42c-069e-2581-e053-d805fe0acbaa 171
The Present and the Future of Neuroimaging in Amyotrophic Lateral Sclerosis, file e27ce426-c972-2581-e053-d805fe0acbaa 167
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients., file e27ce427-0bb0-2581-e053-d805fe0acbaa 167
ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons, file e27ce428-b24d-2581-e053-d805fe0acbaa 167
Pain in amyotrophic lateral sclerosis, file e27ce42b-81e9-2581-e053-d805fe0acbaa 167
Correlation between Apolipoprotein E genotype and brain metabolism in amyotrophic lateral sclerosis, file e27ce42f-99c9-2581-e053-d805fe0acbaa 167
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion, file e27ce42d-613f-2581-e053-d805fe0acbaa 166
The MITOS system predicts long-term survival in amyotrophic lateral sclerosis, file e27ce428-b907-2581-e053-d805fe0acbaa 163
No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis, file e27ce426-f25b-2581-e053-d805fe0acbaa 160
A Distinct MR Imaging Phenotype in Amyotrophic Lateral Sclerosis: Correlation between T1 Magnetization Transfer Contrast Hyperintensity along the Corticospinal Tract and Diffusion Tensor Imaging Analysis., file e27ce427-d7f1-2581-e053-d805fe0acbaa 156
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS, file 9fdbff8d-7026-4818-baba-aaba9bc2ca6f 155
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis, file e27ce42b-0eeb-2581-e053-d805fe0acbaa 155
Clinical phenotypes and radiological findings in frontotemporal dementia related to TARDBP mutations, file e27ce427-0553-2581-e053-d805fe0acbaa 154
Amyotrophic Lateral Sclerosis Incidence and Previous Prescriptions of Drugs for the Nervous System, file e27ce42a-dcfc-2581-e053-d805fe0acbaa 154
Erythropoietin in amyotrophic lateral sclerosis: A multicentre, randomised, double blind, placebo controlled, phase III study, file e27ce428-b250-2581-e053-d805fe0acbaa 153
Acute, Hemorrhagic, Necrotizing Pancreatitis Associated With Riluzole Treatment in a Patient With Amyotrophic Lateral Sclerosis, file e27ce431-fe16-2581-e053-d805fe0acbaa 146
Decreased Levels of Foldase and Chaperone Proteins Are Associated with an Early-Onset Amyotrophic Lateral Sclerosis, file e27ce42b-ad28-2581-e053-d805fe0acbaa 145
Proteostasis and ALS: Protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS), file e27ce42f-2e8f-2581-e053-d805fe0acbaa 145
Serum C-reactive protein as a prognostic biomarker in amyotrophic lateral sclerosis, file e27ce42d-1597-2581-e053-d805fe0acbaa 139
The multistep hypothesis of ALS revisited: The role of genetic mutations, file e27ce42d-009a-2581-e053-d805fe0acbaa 138
A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanisms, file e27ce430-5652-2581-e053-d805fe0acbaa 135
Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis, file e27ce42d-14fe-2581-e053-d805fe0acbaa 130
Professor Camillo Negros Neuropathological Films, file e27ce431-e255-2581-e053-d805fe0acbaa 127
Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis, file e27ce42d-3f74-2581-e053-d805fe0acbaa 125
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients, file e27ce428-bd7f-2581-e053-d805fe0acbaa 124
Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial), file e27ce42d-009c-2581-e053-d805fe0acbaa 122
Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosis, file e27ce42f-27e8-2581-e053-d805fe0acbaa 115
Degenerative neuromuscular diseases: Crucial gene and cell machinery discoveries, file e27ce432-11ae-2581-e053-d805fe0acbaa 113
Multicenter validation of [18F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controls, file e27ce42c-b6df-2581-e053-d805fe0acbaa 109
NADPH oxidases as drug targets and biomarkers in neurodegenerative diseases: What is the evidence?, file e27ce42c-b94b-2581-e053-d805fe0acbaa 101
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials, file e27ce42f-3182-2581-e053-d805fe0acbaa 100
Referral bias in ALS epidemiological studies, file e27ce42c-c699-2581-e053-d805fe0acbaa 99
Lifetime sport practice and brain metabolism in Amyotrophic Lateral Sclerosis, file e27ce431-6901-2581-e053-d805fe0acbaa 99
Multimodal structural MRI in the diagnosis of motor neuron diseases, file e27ce42c-b94d-2581-e053-d805fe0acbaa 98
A Dynamic Bayesian Network model for the simulation of Amyotrophic Lateral Sclerosis progression, file e27ce42f-27e6-2581-e053-d805fe0acbaa 98
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian consensus conference on pain in neurorehabilitation, file e27ce42e-ff96-2581-e053-d805fe0acbaa 94
C9ORF72 hexanucleotide repeat exerts toxicity in a stable, inducible motor neuronal cell model, which is rescued by partial depletion of Pten, file e27ce42e-d2d5-2581-e053-d805fe0acbaa 93
Stratification of amyotrophic lateral sclerosis patients: A crowdsourcing approach, file e27ce42f-2e96-2581-e053-d805fe0acbaa 93
Cognitive impairment across ALS clinical stages in a population-based cohort, file e27ce430-0a2e-2581-e053-d805fe0acbaa 89
Use of multimodal imaging and clinical biomarkers in presymptomatic carriers of C9orf72 repeat expansion, file e27ce431-a704-2581-e053-d805fe0acbaa 86
The transcription factor Nurr1 is up-regulated in Amyotrophic Lateral Sclerosis patients and SOD1-G93A mice, file e27ce42f-6469-2581-e053-d805fe0acbaa 85
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis, file e27ce42d-9e95-2581-e053-d805fe0acbaa 84
Genetic analysis of amyotrophic lateral sclerosis identifies contributing pathways and cell types, file e27ce431-86c6-2581-e053-d805fe0acbaa 84
Comparative analysis of C9Orf72 and sporadic disease in a large multicenter ALS population: The effect of Male sex on survival of C9Orf72 positive patients, file e27ce42f-2f3e-2581-e053-d805fe0acbaa 82
Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk Gene, file e27ce431-9972-2581-e053-d805fe0acbaa 82
Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol, file cd0196a5-7b47-4fd2-b577-2f51b7923ffb 81
Factors predicting survival in ALS: a multicenter Italian study, file e27ce433-7973-2581-e053-d805fe0acbaa 81
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: Protocol for a phase II RCT with futility design (ProMISe trial), file e27ce42d-1593-2581-e053-d805fe0acbaa 80
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial), file e27ce42f-c708-2581-e053-d805fe0acbaa 80
Clinical staging in amyotrophic lateral sclerosis: Analysis of Edaravone Study 19, file e27ce431-a727-2581-e053-d805fe0acbaa 80
Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials, file e27ce42d-1590-2581-e053-d805fe0acbaa 78
July 2017 ENCALS statement on edaravone, file e27ce42d-5388-2581-e053-d805fe0acbaa 77
Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy., file e27ce433-83a1-2581-e053-d805fe0acbaa 77
TRICALS: creating a highway toward a cure, file e27ce431-9a3c-2581-e053-d805fe0acbaa 75
Secular trends of amyotrophic lateral sclerosis: The Piemonte and Valle d’Aosta register, file e27ce42c-5bf7-2581-e053-d805fe0acbaa 74
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation, file e27ce42c-b954-2581-e053-d805fe0acbaa 74
Totale 30.564
Categoria #
all - tutte 44.139
article - articoli 0
book - libri 0
conference - conferenze 312
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.451


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.379 0 0 0 0 0 0 0 0 0 363 596 420
2019/20205.130 375 357 345 631 430 322 386 442 598 452 398 394
2020/20216.111 274 470 396 357 669 464 567 460 583 633 584 654
2021/20227.269 649 460 507 892 767 487 508 456 576 483 979 505
2022/20235.998 309 440 866 676 480 446 477 464 575 563 442 260
2023/20242.490 198 211 305 226 336 271 298 336 104 205 0 0
Totale 32.704